Atenolol often is used empirically in cats with hypertrophic cardiomyopathy (HCM) before the onset of heart failure, although evidence of efficacy is lacking. Cardiac biomarkers play a critical role in the early detection of subclinical cardiac disease, in the prediction of long-term prognosis, and in monitoring the response to therapy in humans.Circulating concentrations of the biomarkers N-terminal pro-B type natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) will decrease after chronic administration of atenolol PO to cats with severe HCM but no signs of heart failure.Six Maine Coon or Maine Coon cross cats with severe HCM.Cats were treated with atenolol (12.5 mg PO q12 h) for 30 days. No cat had left ventricular dynamic outfl...
OBJECTIVES: The aims of this study were to assess the potential associations between the serum cardi...
Cardiac biomarkers may be used to support diagnosis of diseases such as hypertrophic cardiomyopathy ...
Background: Increased plasma concentration of N-terminal-prohormone B-type natriuretic peptide (NT-p...
Atenolol often is used empirically in cats with hypertrophic cardiomyopathy (HCM) before the onset o...
BACKGROUND: N-terminal pro B-type natriuretic peptide (NT-proBNP) and cardiac troponin-I (cTnI) are ...
The aim of this study was to determine if atrial natriuretic peptide can be used as an early screeni...
BACKGROUND: Severe dynamic left ventricular outflow tract obstruction (DLVOTO) secondary to the syst...
Background N‐terminal pro B‐type natriuretic peptide (NT‐proBNP) and cardiac troponin‐I (cTnI) ar...
The purpose of this study was to evaluate the value of measuring plasma NT-proBNP concentration as a...
To evaluate the utility of feline NT-proBNP plasma concentration [NT-proBNP] as a screening tool for...
Myocardial fibrosis occurs in cats with hypertrophic cardiomyopathy (HCM), and is one factor that le...
Feline Arterial Thromboembolism (FATE) is one of the most devastating consequences of cardiac diseas...
Feline arterial thromboembolism (FATE) is a common complication of myocardial disease, often having ...
none7siArrhythmias can complicate cardiac disease in cats and are a potential cause of sudden death....
Background: The benefits of pimobendan in the treatment of congestive heart failure (CHF) in cats wi...
OBJECTIVES: The aims of this study were to assess the potential associations between the serum cardi...
Cardiac biomarkers may be used to support diagnosis of diseases such as hypertrophic cardiomyopathy ...
Background: Increased plasma concentration of N-terminal-prohormone B-type natriuretic peptide (NT-p...
Atenolol often is used empirically in cats with hypertrophic cardiomyopathy (HCM) before the onset o...
BACKGROUND: N-terminal pro B-type natriuretic peptide (NT-proBNP) and cardiac troponin-I (cTnI) are ...
The aim of this study was to determine if atrial natriuretic peptide can be used as an early screeni...
BACKGROUND: Severe dynamic left ventricular outflow tract obstruction (DLVOTO) secondary to the syst...
Background N‐terminal pro B‐type natriuretic peptide (NT‐proBNP) and cardiac troponin‐I (cTnI) ar...
The purpose of this study was to evaluate the value of measuring plasma NT-proBNP concentration as a...
To evaluate the utility of feline NT-proBNP plasma concentration [NT-proBNP] as a screening tool for...
Myocardial fibrosis occurs in cats with hypertrophic cardiomyopathy (HCM), and is one factor that le...
Feline Arterial Thromboembolism (FATE) is one of the most devastating consequences of cardiac diseas...
Feline arterial thromboembolism (FATE) is a common complication of myocardial disease, often having ...
none7siArrhythmias can complicate cardiac disease in cats and are a potential cause of sudden death....
Background: The benefits of pimobendan in the treatment of congestive heart failure (CHF) in cats wi...
OBJECTIVES: The aims of this study were to assess the potential associations between the serum cardi...
Cardiac biomarkers may be used to support diagnosis of diseases such as hypertrophic cardiomyopathy ...
Background: Increased plasma concentration of N-terminal-prohormone B-type natriuretic peptide (NT-p...